OM-MOG rapidly increases PD-L1- and IL-10-producing myeloid cells and maintains high levels of Chi3l3 expression in secondary lymphoid organs during EAE, and within this type 2 immune environment induces antigen-specific T cell anergy without affecting the responses of other T cells. The gene discussed is IL10; the disease is ocular melanoma.